MNA vs. CNCR ETF Comparison

Comparison of IQ Merger Arbitrage ETF (MNA) to Loncar Cancer Immunotherapy ETF (CNCR)
MNA

IQ Merger Arbitrage ETF

MNA Description

The investment seeks investment results that correspond generally to the price and yield performance of its underlying index, the IQ Merger Arbitrage Index. The fund employs a "passive management" to track the performance of the underlying index, which was developed by Financial Development Holdco LLC ("IndexIQ"). The underlying index seeks to employ a systematic investment process designed to identify opportunities in companies whose equity securities trade in developed markets, including the U.S., and which are involved in announced mergers, acquisitions and other buyout-related transactions. It is non-diversified.

Grade (RS Rating)

Last Trade

$31.15

Average Daily Volume

53,079

Number of Holdings *

29

* may have additional holdings in another (foreign) market
CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$15.41

Average Daily Volume

44,018

Number of Holdings *

71

* may have additional holdings in another (foreign) market
Performance
Period MNA CNCR
30 Days -0.22% 0.57%
60 Days -1.30% -8.68%
90 Days 0.42% 5.41%
12 Months -0.77% 16.19%
1 Overlapping Holdings
Symbol Grade Weight in MNA Weight in CNCR Overlap
INBX D 0.61% 1.28% 0.61%
MNA Overweight 28 Positions Relative to CNCR
Symbol Grade Weight
HES B 7.4%
PXD B 7.39%
DFS C 6.45%
ANSS D 6.37%
X D 6.23%
ETRN B 6.13%
CTLT C 5.62%
JNPR D 4.83%
CPRI F 3.84%
CERE B 2.88%
AMED D 2.7%
FUSN A 2.51%
SIX C 2.49%
AXNX C 2.39%
DOOR A 2.18%
OLK D 1.84%
VZIO D 1.12%
MGRC D 1.06%
SRCL D 0.86%
HAYN D 0.81%
SP C 0.77%
EVBG B 0.75%
NS D 0.65%
HA D 0.61%
NWLI A 0.53%
TAST A 0.37%
XT D -0.25%
XOP B -6.21%
MNA Underweight 70 Positions Relative to CNCR
Symbol Grade Weight
GERN B -3.05%
CGEM B -2.17%
ACRV C -2.12%
DCPH A -2.08%
ELVN B -2.05%
JANX B -2.01%
NUVB B -1.91%
DAWN B -1.63%
RVMD B -1.59%
TSVT C -1.52%
HCM B -1.46%
ITOS C -1.44%
YMAB B -1.44%
XNCR B -1.42%
BPMC B -1.41%
MRK B -1.4%
LYEL C -1.38%
MRUS B -1.38%
BCYC D -1.38%
TYRA C -1.35%
AURA F -1.34%
IPHA D -1.32%
ERAS C -1.31%
SMMT A -1.29%
MOR C -1.28%
PGEN D -1.28%
SDGR F -1.28%
IMCR C -1.28%
MGNX D -1.27%
FHTX F -1.27%
BNTX D -1.27%
EXEL D -1.27%
SNDX C -1.27%
RAPT F -1.27%
GLUE D -1.27%
VOR F -1.25%
SWTX D -1.24%
GMAB F -1.24%
REGN C -1.24%
NRIX C -1.22%
STRO C -1.22%
KURA C -1.21%
IGMS C -1.21%
KYMR C -1.2%
IDYA C -1.2%
IMTX D -1.18%
IOVA C -1.15%
RCUS F -1.11%
BMY F -1.1%
NUVL D -1.09%
PRLD D -1.09%
RLAY F -1.07%
ZNTL F -1.05%
KPTI F -1.05%
DNA F -1.04%
RXRX F -1.01%
ACLX D -0.98%
ACET F -0.97%
REPL F -0.96%
ARVN D -0.95%
AUTL F -0.92%
BMEA F -0.9%
CRBU F -0.9%
MRSN D -0.88%
LEGN F -0.87%
ALLO F -0.85%
RPTX F -0.83%
FATE F -0.74%
GNLX F -0.69%
IMRX F -0.69%
Compare ETFs